Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

Features and News

5 Best Performing Bull Run Equity ETFs

Since the U.S. stock market bottomed seven years ago, these equity ETFs have risen sharply.

Daily ETF Watch

Daily ETF Watch: Ex-China Fund Debuts

Emerging Global Advisors rolls out an ex-China emerging market ETF.

Features and News

This Bull Market’s 10 Best Performing ETFs

These funds showed the best returns during this six-year bull run.

Features and News

Hot 'Smart Beta' ETFs

Here are some noncap-weighted funds that are outperforming.

Features and News

The Vivus ETF Effect

The SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) and the PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP) nearly doubled their 2012 returns on Thursday, after an obesity drug from the biotech firm Vivus won approval from federal regulators, according to an article in Barron's.

Features and News

Are HOLDRS Still Worth Holding?

HOLDRS are dinosaurs, but not all of them are going extinct.